Neurology 1502 - Neurology Alert - Feb 01, 2011

Target Audience:

This activity is intended for the neurologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders

John J. Caronna, MD
Professor of Clinical Neurology;
Specialty area, Stroke and General Neurology

Claire Henchcliffe, MD, DPhil
Associate Professor of Neurology and Neuroscience;
Specialty area, Movement Disorders

Jordan Dubow, MD
Vascular Neurology Fellow
Weill Cornell Medical College

Sabiha Merchant, MD
Attending Pediatric Neurology;
Director, Pediatric Epilepsy Fellowship
New York Presbyterian Hospital

Steven Weinstein, MD. Dr. Merchant is
Director, Pediatric Comprehensive Epilepsy Program
Weill Cornell Medical College


  • Vascular Endothelial Growth Factor and Neuropathy
  • The ABCs of Anosognosia for Hemiplegia
  • Sleep Disorders and Restless Legs Syndrome in Friedreich's Ataxia
  • Gait Ataxia in Essential Tremor Modulated by Thalamic Deep Brain Stimulation
  • A Hereditary, Childhood Form of Parkinsonism
  • Stroke Alert: A Review of Current Clinical Stroke Literature


  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert is editor in chief, Matthew Fink, MD, reports no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study. Assistant editors Michael Rubin, MD, John J. Caronna, MD, author Jordan Dubow, MD, and peer reviewer M. Flint Beal, MD, report no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study. Assistant editor Claire Henchcliffe, MD, DPhil reports she is on the speaker's bureau and advisory board for Allergan and Teva; speaker's bureau for Boehringer-Ingelheim, GlaxoSmithKline, and Novartis; advisory board for Merz, and is a consultant for Gerson Lehman Group and Guidepoint Global.

Copyright 2011 AHC Media. All rights reserved.